Monthly News Roundup - March 2015

FDA Approves First Biosimilar Product Zarxio On Friday, March 6th the U.S. Food and Drug Administration (FDA) approved Sandoz’s Zarxio (filgrastim-sndz), the first U.S. approved biosimilar. Zarxio, the biosimilar for Amgen’s filgrastim...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news